Letter Sequence Supplement |
|---|
EPID:L-2018-LLA-0194, License Amendment Request and Exemption Request to Support the Implementation of Framatome High Thermal Performance Fuel (Approved, Closed) |
|
MONTHYEARML18187A4172018-07-0606 July 2018
License Amendment Request and Exemption Request to Support the Implementation of Framatome High Thermal Performance Fuel
Project stage: Request
ML18271A0392018-10-0202 October 2018
Non Proprietary - Supplemental Information Needed for Acceptance of Requested License Amendments and Exemptions Implementation of Framatome High Thermal Performance Fuel (Epids L-2018-LLA-0194 and L-2018-LLE-0010)
Project stage: Acceptance Review
ML18296A4662018-10-18018 October 2018
Supplemental Information Regarding License Amendment Request and Exemption Request to Support the Implementation of Framatome High Thermal Performance Fuel
Project stage: Supplement
ML18312A3322018-11-13013 November 2018
Acceptance Review for License Amendment and Exemption Requests Regarding the Implementation of Framatome High Thermal Performance Fuel
Project stage: Acceptance Review
ML18333A2272018-12-0404 December 2018
Request for Withholding Information from Public Disclosure, Affidavit Dated October 18, 2018, Executed by Mr. Bruce Rash of APS
Project stage: Withholding Request Acceptance
ML18333A1632018-12-0404 December 2018
Request for Withholding Information from Public Disclosure, Affidavit Dated July 6, 2018, Executed by Mr. Bruce Rash of APS
Project stage: Withholding Request Acceptance
ML18333A0712018-12-0404 December 2018
Request for Withholding Information from Public Disclosure, Affidavit Dated May 16, 2018, Executed by Mr. Philip A. Opsal, from Framatome, Inc
Project stage: Withholding Request Acceptance
ML18333A0592018-12-0404 December 2018
Request for Withholding Information from Public Disclosure, Affidavit Dated March 9, 2018, Executed by Mr. Philip A. Opsal, from Framatome, Inc
Project stage: Withholding Request Acceptance
ML19011A1082019-01-15015 January 2019
First Regulatory Audit Plan for January 22-23, 2019, in Support of Framatome
Project stage: Other
ML19060A2982019-03-0101 March 2019
Transmittal of Audit Presentation Slides Regarding License Amendment Request and Exemption Request to Support the Implementation of Framatome CE16HTP Fuel
Project stage: Request
ML19065A2542019-03-18018 March 2019
Request for Withholding Information from Public Disclosure, Affidavit Dated February 28, 2019, Executed by Mr. Bruce Rash, Arizona Public Service Company
Project stage: Withholding Request Acceptance
ML19065A2212019-03-18018 March 2019
Request for Withholding Information from Public Disclosure, Affidavit Dated February 22, 2019, Executed by Mr Philip A. Opsal, Framatome, Inc
Project stage: Withholding Request Acceptance
ML19098A1872019-04-0505 April 2019
NRR E-mail Capture - Palo Verde 1, 2, and 3 - Official RAIs from Irab for Framatome Htp Fuel LAR and Exemption (EPIDs L-2018-LLA-0194 and L-2018-LLE-0010)
Project stage: RAI
ML19137A1182019-05-17017 May 2019
Response to NRC Staff Request for Additional Information from Reactor Assessment and Human Performance Branch Regarding License Amendment and Exemption Requests Related to the Implementation of Framatome High Thermal
Project stage: Request
ML19154A4692019-06-0404 June 2019
Second Regulatory Audit Plan for June 17-20, 2019, in Support of Framatome High Thermal Performance Fuel License Amendment Request and Exemption
Project stage: Other
ML19218A2932019-08-13013 August 2019
Regulatory Audit Report for the January 22-23, 2019, Audit for the License Amendment and Exemption Requests Assoc. W/Framatome High Thermal Performance Fuel (EPID L-2018-LLA-0194; EPID L-2018-LLE-0010)
Project stage: Other
ML19234A3202019-08-29029 August 2019
Redacted - Request for Additional Information for Amendment and Exemption Request to Support the Implementation of Framatome High Thermal Performance Fuel (EPID L-2018-LLA-0194; EPID L-2018-LLE-0010)
Project stage: RAI
ML19235A2562019-09-0909 September 2019
Regulatory Audit Summary for the June 17-20, 2019, Audit for the License Amendment and Exemption Requests Associated with Framatome High Thermal Performance Fuel
Project stage: Other
ML19277J4572019-10-0404 October 2019
Response to NRC Request for Additional Information Regarding License Amendment and Exemption Requests Related to the Implementation of Framatome CE16HTP Fuel
Project stage: Response to RAI
ML19282C4432019-10-21021 October 2019
Request for Withholding Information from Public Disclosure - 5/29/19 Affidavit Executed by Nathan Hottle, Framatome, Inc. ANP-3785P, Revision 0
Project stage: Withholding Request Acceptance
ML19282A6702019-10-24024 October 2019
Request for Withholding Information from Public Disclosure, 10/4/19 Affidavit Executed by Bruce Rash, Arizona Public Service Company RAI Responses
Project stage: RAI
ML19282B6432019-10-24024 October 2019
Request for Withholding Information from Public Disclosure, 9/25/19 Affidavit Executed by Gayle Elliott, Framatome, Inc. ANP-3639P, Revision 1Q1P, Revision 0, and ANP-3640Q1P, Revision 0
Project stage: Withholding Request Acceptance
ML19301A9052019-10-30030 October 2019
Third Regulatory Audit Plan for November 7-8, 2019, in Support of Framatome High Thermal Performance Fuel License Amendment Request and Exemption
Project stage: Other
ML19331A3612019-11-26026 November 2019
Supplemental Response to NRC Request for Additional Information Regarding License Amendment and Exemption Requests Related to the Implementation of Framatome CE16HTP Fuel
Project stage: Supplement
ML19337A4992019-12-18018 December 2019
Request for Withholding Information from Public Disclosure Related to 11/14/19 Affidavit Executed by K. Hosack, Westinghouse
Project stage: Withholding Request Acceptance
ML19337A0322019-12-18018 December 2019
Request for Withholding Information from Public Disclosure, 11/25/19 Affidavit Executed by Mr. Phil Opsal, Framatome, Inc. Framatome ANP-3640Q2P, Revision 0
Project stage: Withholding Request Acceptance
ML19337A0372019-12-18018 December 2019
Request for Withholding Information from Public Disclosure, 10/25/19 Affidavit Executed by Bruce Rash, Arizona Public Service Company RAI Responses Dated 11/26/19
Project stage: RAI
ML19353C0382019-12-19019 December 2019
Supplemental Information Related to Framatome CE16HTP Fuel LAR Requests for Additional Information Bhtp RAl-05 and Bhtp RAl-06
Project stage: Supplement
ML20031D6012020-02-13013 February 2020
Audit Summary for the Nov. 7-8, 2019, Audit for the License Amendment and Exemption Requests Associated with Framatome High Thermal Performance Fuel (EPID L-2018-LLA-0194 & EPID L-2018-LLE-0010)
Project stage: Other
ML20050C9742020-02-19019 February 2020
NRR E-mail Capture - Palo Verde 1,2, and 3 - Framatome Htp Fuel LAR and Exemption Third Audit Summary (EPIDs L-2018-LLA-0194 and L-2018-LLE-0010)
Project stage: Approval
ML20031C9472020-03-0404 March 2020
Nonproprietary, Issuance of Amendment Nos. 212, 212, and 212 to Revise Technical Specifications to Support the Implementation of Framatome High Thermal Performance Fuel
Project stage: Approval
2019-12-18
[Table View] |
Text
10 CFR 50.90 10 CFR 50.12 t'l aps MARIA L. LACAL Senior Vice President Nuclear Regulatory & Oversight Palo Verde 102-08030-MLL/MDD December 19, 2019 Nuclear Generating Station P.O. Box 52034 Phoenix, AZ 85072 Mail Station 7605 Tel 623.393.649 1 U. S. Nuclear Regulatory Commission ATIN: Document Control Desk Washington, DC 20555-0001
References:
- 1. Arizona Public Service Company (APS) letter number 102-07727, License Amendment Request (LAR) and Exemption Request to Support the Implementation of Framatome High Thermal Performance Fuel, dated July 6, 2018, Agencywide Documents Access and Management System (ADAMS) Accession Numbers ML18187A417 (non-proprietary) and ML18187A418 (proprietary)
Dear Sir:
Subject:
- 2. APS letter number 102-008012, Response to NRC Request for Additional Information Regarding License Amendment and Exemption Requests Related to the Implementation of Framatome CE16HTP Fuel, dated October 4, 2019, ADAMS Accession Numbers ML19277J457 (non-proprietary) and Mll 9277J458 (proprietary)
Palo Verde Nuclear Generating Station (PVNGS) Units 1, 2, and 3 Docket Nos. STN 50-528, 50-529, and 50-530 Renewed Operating License Nos. NPF-41, NPF-51, and NPF-74 Supplemental Information Related to Framatome CE16HTP Fuel LAR Requests for Additional Information BHTP RAl-05 and BHTP RAl-06 By letter dated July 6, 2018 (Reference 1), Arizona Public Service Company (APS) submitted a license amendment request (LAR) pursuant to the provisions of Section 50.90 of Title 10 of the Code of Federal Regulations (10 CFR) and an exemption request pursuant to the provisions of 10 CFR 50.12, to request approval of proposed changes to the PVNGS Technical Specifications (TS) to support the implementation of Framatome CE16HTP fuel with MS cladding and gadolinia as a burnable absorber. By letter dated October 4, 2019 (Reference 2), APS provided additional information in response to an NRC staff request for additional information (RAI), which included responses to specific NRC staff RAis BHTP RAl-05 and BHTP RAl-06.
Subsequent to the submittal of Reference 2, APS was informed by Framatome of an issue regarding the Test 51 results and design limit value reported in the NRC approved Topical Report BAW-10241(P)(A), Revision 0, BHTP Correlation Applied in LYNXT (ADAMS Accession Number ML043650303). Data from this topical report was used in the VIPRE to LYNXT A member of the STARS Alliance, LLC Callaway, Diablo Canyon
, Palo Verde
, Wolf Creek
102-08030-M LL/M DD ATTN: Document Control Desk U. S. Nuclear Regulatory Commission Supplemental Information Related to Framatome CE16HTP Fuel LAR Requests for Additional Information BHTP RAI-05 and BHTP RAI-06 Page 2 comparisons provided in the BHTP RAI-05 and BHTP RAI-06 responses in Reference 2. The issue impacts the Test 51 VIPRE to LYNXT comparisons. The APS VIPRE analyses which are the basis for the proposed PVNGS departure from nucleate boiling ratio limit and associated statistical data are not affected by this issue. This issue was entered into both the PVNGS and Framatome corrective action programs.
Framatome performed an evaluation of the Test 51 error in accordance with their corrective action program. Framatome's review concluded that the impact on the reported information is minor and that correcting the issue will slightly improve the agreement between the VIPRE and LYNXT results for Test 51. Therefore, APS and Framatome agree that the conclusions in the RAI responses remain valid.
As a part of the PVNGS corrective action program, the correction to Framatome Topical Report BAW-10241(P)(A) will be incorporated into the PVNGS Core Operating Limits Report as required by Technical Specification 5.6.5. As required by the PVNGS corrective action program, any impacted analyses will be updated as required to account for the correction to BAW-10241(P)(A).
No commitments are being made to the NRC by this letter. If you have any questions about this request, please contact Michael D. Dilorenzo, Licensing Department Leader, at (623) 393-3495.
I declare under penalty of perjury that the foregoing is true and correct.
Executed on:
December 19, 2019 Sincerely,
\\
/l-tc~ '"~ x;._ (1, __ {_ __
MLL/MDD/mg cc:
S. A. Morris S. P. Lingam C. A. Peabody NRC Region IV Regional Administrator NRC NRR Project Manager for PVNGS NRC Senior Resident Inspector for PVNGS
